China Diabetes Care Devices Market Outlook to 2033 – Insulin Delivery and Glucose Monitoring

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: February 18, 2025 Report Code: GDME0649MDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “China Diabetes Care Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the China Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Glucose Monitoring and Insulin Delivery

The China Diabetes Care Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Diabetes Care Devices Market.
• Global corporate-level profiles of key companies operating within the China Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Diabetes Care Devices is segmented as follows –

• Glucose Monitoring

• Insulin Delivery

Reasons to Buy

Key Reasons to Purchase – The China Diabetes Care Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Novo Nordisk AS_x000D_
Sanofi_x000D_
Medtronic Plc_x000D_
Eli Lilly and Co_x000D_
F. Hoffmann-La Roche Ltd_x000D_
Abbott Laboratories

1 Table of Contents_x000D_

1.1 List of Tables_x000D_

1.2 List of Figures_x000D_

2 Introduction_x000D_

2.1 What Is This Report About?_x000D_

2.2 Diabetes Care Devices Market Segmentation_x000D_

2.3 Definitions of Markets Covered in the Report_x000D_

3 Diabetes Care Devices Market, China_x000D_

3.1 Diabetes Care Devices Market, China, Revenue ($m), 2018-2033_x000D_

3.2 Diabetes Care Devices Market, China, Revenue Mix ($m), 2023_x000D_

3.3 Diabetes Care Devices Market, China, Category Contribution by Revenue ($m), 2023_x000D_

3.4 Diabetes Care Devices Market, China, Revenue ($m), 2018-2033_x000D_

3.5 Diabetes Care Devices Market, China, Volume (Units), 2018-2033_x000D_

3.6 Diabetes Care Devices Market, China, Volume (Units), 2018-2033_x000D_

3.7 Diabetes Care Devices Market, China, Company Share by Revenue ($m), 2023_x000D_

4 Glucose Monitoring Market, China_x000D_

4.1 Glucose Monitoring Market, China, Revenue ($m), 2018-2033_x000D_

4.1.1 Blood Glucose Meters Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

4.2 Glucose Monitoring Market, China, Volume (Units), 2018-2033_x000D_

4.2.1 Blood Glucose Meters Market, China, Volume (Units), by Segment, 2018-2033_x000D_

4.3 Glucose Monitoring Market, China, Average Price ($), 2018-2033_x000D_

4.4 Glucose Monitoring Market, China, Distribution Share by Revenue ($m), 2023_x000D_

4.5 Glucose Monitoring Market, China, Company Share by Revenue ($m), 2023_x000D_

5 Insulin Delivery Market, China_x000D_

5.1 Insulin Delivery Market, China, Revenue Mix ($m), 2023_x000D_

5.2 Insulin Delivery Market, China, Segment Contribution (%), 2023_x000D_

5.3 Insulin Delivery Market, China, Revenue ($m), 2018-2033_x000D_

5.3.1 Insulin Pens Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

5.3.2 Insulin Pumps Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

5.4 Insulin Delivery Market, China, Volume (Units), 2018-2033_x000D_

5.4.1 Insulin Pens Market, China, Volume (Units), by Segment, 2018-2033_x000D_

5.4.2 Insulin Pumps Market, China, Volume (Units), by Segment, 2018-2033_x000D_

5.5 Insulin Delivery Market, China, Average Price ($) , 2018-2033_x000D_

5.6 Insulin Delivery Market, China, Distribution Share by Revenue ($m), 2023_x000D_

5.7 Insulin Delivery Market, China, Company Share by Revenue ($m), 2023_x000D_

6 Overview of Key Companies in China, Diabetes Care Devices Market_x000D_

6.1 Abbott Laboratories_x000D_

6.1.1 Company Overview_x000D_

6.2 Novo Nordisk AS_x000D_

6.2.1 Company Overview_x000D_

6.3 Medtronic Plc_x000D_

6.3.1 Company Overview_x000D_

6.4 Sanofi_x000D_

6.4.1 Company Overview_x000D_

6.5 Eli Lilly and Co_x000D_

6.5.1 Company Overview_x000D_

6.6 F. Hoffmann-La Roche Ltd_x000D_

6.6.1 Company Overview_x000D_

6.7 DexCom Inc_x000D_

6.7.1 Company Overview_x000D_

7 Diabetes Care Devices Market Pipeline Products_x000D_

8 Financial Deals Landscape_x000D_

8.1 Acquisition_x000D_

8.1.1 Otsuka Holdings May Sell Stake in MicroPort Scientific_x000D_

8.1.2 Sansure Biotech to Acquire

21.96% Stake in Hunan Shengwei Sumin Biotech for USD2.21 Million_x000D_

8.2 Private Equity_x000D_

8.2.1 Queshi Zhiji Private Securities Investment Fund No 2 to Acquire

5.62% in Shanghai Shenqi Pharmaceutical Investment Management (Shanghai Miracle) for USD26.65 Million_x000D_

8.3 Venture Financing_x000D_

8.3.1 Shanghai Injexin Medical Technology Raises Funds through Series A Financing_x000D_

8.3.2 Zhixin Haozheng (Shanghai) Pharmaceutical Technology Secures Pre-A+ Round of Financing_x000D_

8.3.3 Hangzhou Baiyi Pharma Raises Funds through Venture Financing_x000D_

8.3.4 Hangzhou Baiyi Health Technology Raises Funds through Venture Financing_x000D_

8.3.5 Muxin Technology Secures Series A Financing_x000D_

8.3.6 Shanghai Yingjiexin Medical Technology (Enjosim) Secures Pre Series A Financing_x000D_

9 Recent Developments_x000D_

9.1 Government and Public Interest_x000D_

9.1.1 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo_x000D_

9.1.2 Jun 27, 2024: InTec PRODUCTS Participate in ISBT2024_x000D_

9.2 Legal And Regulatory_x000D_

9.2.1 May 29, 2024: Gan & Lee Pharmaceuticals Pass the EMA Pre-Approval (GMP) Inspection_x000D_

9.3 Other Significant Developments_x000D_

9.3.1 May 22, 2024: The Brazilian President attended the inauguration ceremony of Gan & Lee''s partner insulin factory_x000D_

9.3.2 Apr 08, 2024: Researchers Unravel Glucose-Sensing Mechanism That Controls Thermogenesis_x000D_

9.4 Product News_x000D_

9.4.1 Sep 18, 2024: HKU Engineering Team Develops Next-Generation Wearable Continuous Glucose Monitoring System for Diabetes Management_x000D_

9.4.2 Jul 12, 2024: Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in Diabetes Management_x000D_

10 Appendix_x000D_

10.1 Research Methodology_x000D_

10.1.1 Coverage_x000D_

10.1.2 Secondary Research_x000D_

10.1.3 Primary Research_x000D_

10.1.4 Market Modeling and Forecasting_x000D_

10.1.5 Company Share Analysis_x000D_

10.1.6 Distribution Share Analysis_x000D_

10.1.7 Benchmarking_x000D_

10.2 GlobalData Consulting_x000D_

10.3 Contact Us_x000D_

10.4 Disclaimer

Table

Table 1: Diabetes Care Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 2: Diabetes Care Devices Market, China, Category Contribution by Revenue ($m), 2023

Table 3: Diabetes Care Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 4: Diabetes Care Devices Market, China, Volume (Units), 2018-2033

Table 5: Diabetes Care Devices Market, China, Volume (Units), 2018-2033

Table 6: Diabetes Care Devices Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 7: Glucose Monitoring Market, China, Revenue ($m), USD Constant, 2018-2033

Table 8: Blood Glucose Meters Market, China, Revenue ($m), USD Constant, 2018-2033

Table 9: Glucose Monitoring Market, China, Volume (Units), 2018-2033

Table 10: Blood Glucose Meters Market, China, Volume (Units), 2018-2033

Table 11: Glucose Monitoring Market, China, Average Price ($), 2018-2033

Table 12: Glucose Monitoring Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 13: Glucose Monitoring Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 14: Insulin Delivery Market, China, Segment Contribution (%), 2023

Table 15: Insulin Delivery Market, China, Revenue ($m), USD Constant, 2018-2033

Table 16: Insulin Pens Market, China, Revenue ($m), USD Constant, 2018-2033

Table 17: Insulin Pumps Market, China, Revenue ($m), USD Constant, 2018-2033

Table 18: Insulin Delivery Market, China, Volume (Units), 2018-2033

Table 19: Insulin Pens Market, China, Volume (Units), 2018-2033

Table 20: Insulin Pumps Market, China, Volume (Units), 2018-2033

Table 21: Insulin Delivery Market, China, Average Price ($), 2018-2033

Table 22: Insulin Delivery Market, China, Distribution Share by Revenue ($m), USD Constant, 2023

Table 23: Insulin Delivery Market, China, Company Share by Revenue ($m), USD Constant, 2023

Table 24: Diabetes Care Devices Market Pipeline Products

Table 25: Otsuka Holdings May Sell Stake in MicroPort Scientific

Table 26: Sansure Biotech to Acquire 21.96% Stake in Hunan Shengwei Sumin Biotech for USD2.21 Million

Table 27: Queshi Zhiji Private Securities Investment Fund No 2 to Acquire 5.62% in Shanghai Shenqi Pharmaceutical Investment Management (Shanghai Miracle) for USD26.65 Million

Table 28: Shanghai Injexin Medical Technology Raises Funds through Series A Financing

Table 29 Zhixin Haozheng (Shanghai) Pharmaceutical Technology Secures Pre-A+ Round of Financing

Table 30: Hangzhou Baiyi Pharma Raises Funds through Venture Financing

Table 31: Hangzhou Baiyi Health Technology Raises Funds through Venture Financing

Table 32: Muxin Technology Secures Series A Financing

Table 33: Shanghai Yingjiexin Medical Technology (Enjosim) Secures Pre Series A Financing

Figures

Figure 1: Diabetes Care Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 2: Diabetes Care Devices Market, China, Revenue Mix ($m), 2023

Figure 3: Diabetes Care Devices Market, China, Category Contribution (%), 2023

Figure 4: Diabetes Care Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 5: Diabetes Care Devices Market, China, Volume (Units), 2018-2033

Figure 6: Diabetes Care Devices Market, China, Volume (Units), 2018-2033

Figure 7: Diabetes Care Devices Market, China, Company Share (%) 2023

Figure 8: Glucose Monitoring Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 9: Blood Glucose Meters Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 10: Glucose Monitoring Market, China, Volume (Units), 2018-2033

Figure 11: Blood Glucose Meters Market, China, Volume (Units), 2018-2033

Figure 12: Glucose Monitoring Market, China, Company Share (%) 2023

Figure 13: Insulin Delivery Market, China, Revenue Mix ($m), 2023

Figure 14: Insulin Delivery Market, China, Segment Contribution (%), 2023

Figure 15: Insulin Delivery Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 16: Insulin Pens Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 17: Insulin Pumps Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 18: Insulin Delivery Market, China, Volume (Units), 2018-2033

Figure 19: Insulin Pens Market, China, Volume (Units), 2018-2033

Figure 20: Insulin Pumps Market, China, Volume (Units), 2018-2033

Figure 21: Insulin Delivery Market, China, Company Share (%) 2023

China Diabetes Care Devices Market Outlook to 2033 – Insulin Delivery and Glucose Monitoring standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diabetes Care Devices reports

Medical Devices

New

Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at China Diabetes Care Devices Market Outlook to 2033 – Insulin Delivery and Glucose Monitoring in real time.

Access a live China Diabetes Care Devices Market Outlook to 2033 – Insulin Delivery and Glucose Monitoring dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

China Diabetes Care Devices Market Outlook to 2033 – Insulin Delivery and Glucose Monitoring

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports